| Period Ending | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|
|
Total Revenue
|
1,805,000
|
1,813,000
|
1,783,000
| | Cost of Revenue | 937,000 | 961,000 | 1,003,000 | | |
Gross Profit
|
868,000
|
852,000
|
780,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 318,000 | 316,000 | 275,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 248,000 | 227,000 | 238,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
302,000
|
309,000
|
267,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 10,000 | 6,000 | 17,000 |
|
Earnings Before Interest And Taxes | 312,000 | 315,000 | 284,000 |
|
Interest Expense | 108,000 | 110,000 | 110,000 |
|
Income Before Tax | 204,000 | 205,000 | 174,000 |
|
Income Tax Expense | 64,000 | 58,000 | 53,000 |
|
Minority Interest | 1,000 |
-
| 4,000 |
|
|
|
Net Income From Continuing Ops | 141,000 | 147,000 | 125,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
141,000
|
147,000
|
125,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
141,000
|
147,000
|
125,000
|
|
0.41%